
United States · Biotechnology startup
Amyris is a vertically integrated synthetic biology company that partners with companies across industries to create, scale-up, and manufacture sustainable, market-ready ingredient
Listed
Amyris is a vertically integrated synthetic biology company that partners with companies across industries to create, scale-up, and manufacture sustainable, market-ready ingredient
s utilizing advanced fermentation technology and world-class platforms. Leveraging two decades of experience, we innovate at an unparalleled rate. Our flexible collaboration models enable us to partner with companies at a variety of growth stages to facilitate sustainability and economic objectives while eliminating supply chain obstacles. Our renewable and traceable ingredients are already proven game-changers for the industrials, pharmaceuticals, flavors and fragrances, and beauty, health and wellness industries and are included in thousands of products, reaching millions of consumers.
From Amyris's own website and the SEC filings it signed: 10 on the team.
On the board, as filediAna John DutraFrank John KungGeoffrey John DuykJames John MccannJulie John WashingtonL John DoerrLisa John QiPhilip John EykermanRyan John PanchadsaramSteven John Mills
Add your raise, your deck and your story, and put Amyris in front of investors. Or tell us what we have wrong.